Clinical Efficacy, Safety, and Tolerability of Once-Daily Fesoterodine in Subjects with Overactive Bladder

Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study

Debra E. Irwin, Ian Milsom, Steinar Hunskaar et al. · European Urology · 2006 · 2.6K citations

Medicine, Population Health Sciences, Urology +16

How widespread are the symptoms of an overactive bladder and how are they managed? A population‐based prevalence study

Ian Milsom, Paul Abrams, L. Cardozo et al. · British Journal of Urology · 2001 · 1.8K citations · Full text

Medicine, Internal Medicine, Urology +13

Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder

Philip Van Kerrebroeck, Karl J. Kreder, Udo Jonas et al. · Urology · 2001 · 459 citations

Medicine, Pharmacology, Pharmacotherapy +9

The Validation of the Patient Perception of Bladder Condition (PPBC): A Single-Item Global Measure for Patients with Overactive Bladder

Karin S. Coyne, Louis S. Matza, Zoë Kopp et al. · European Urology · 2006 · 355 citations

Medicine, Psychology, Urology +12

Clinical efficacy and tolerability of extended‐release tolterodine and immediate‐release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo‐controlled trial

Yukio Homma, Jae‐Seung Paick, J.G. Lee et al. · British Journal of Urology · 2003 · 126 citations

Medicine, Pharmacology, Pharmacotherapy +17